Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660

Article  PubMed  CAS  Google Scholar 

Seifert U, Klug SJ (2014) Early detection of cervical cancer in Germany: Evidence and implementation. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 57(3):294–301

Article  PubMed  CAS  Google Scholar 

(2024) Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe,AWMF): S3-Leitlinie Diagnostik, Therapie und Nachsorge der Patientin mit Zervixkarzinom, Langversion, 2.2, 2022. https://www.leitlinienprogramm-onkologie.de/leitlinien/zervixkarzinom/ (Created 05.2024) (AWMF-Registernummer: 032/033OL)

Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ (1999) A randomized trial of pelvic radiation therapy vs no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol 73:177–183

Article  PubMed  CAS  Google Scholar 

Landoni F et al (2017) Randomized study between radical surgery and radiotherapy for the treatment of stage IB-IIA cervical cancer: 20-year update. J Gynecol Oncol 28(e34):3

Google Scholar 

Falcetta FS, Medeiros LR, Edelweiss MI, Pohlmann PR, Stein AT, Rosa DD (2016) Adjuvant platinum-based chemotherapy for early stage cervical cancer. Cochrane Database Syst Rev 22; 11(11):CD5342 (Nov)

Google Scholar 

Schiller K, Combs SE (2021) Effectiveness of sequential vs concurrent chemoradiation or radiation alone in the adjuvant treatment of cervical cancer after hysterectomy. Strahlenther Onkol 197(8):746–748 (Aug)

Article  PubMed  PubMed Central  Google Scholar 

Chen CS, Huang EY (2023) Comparison of Oncologic Outcomes between Radical Hysterectomy and Primary Concurrent Chemoradiotherapy in Women with Bulky IB and IIA CervicalCancer under Risk Stratification. Cancers 2;15(11):3034 (Jun)

Article  PubMed  Google Scholar 

Barbetta A, Sihag S, Nobel T, Hsu M, Tan KS, Bains M, Jones DR, Molena D (2019) Patterns and risk of recurrence in patients with esophageal cancer with a pathologic complete response after chemoradiotherapy followed by surgery. J Thorac Cardiovasc Surg 157(3):1249–1259

Article  PubMed  Google Scholar 

Tepper J et al (2008) Phase III trial of trimodality therapy with cisplatin, fluorouracil,radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol 26(7):1086–1092

Article  PubMed  CAS  Google Scholar 

Sauer R, Becker H, Hohenberger W et al (2004) German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 21;351(17):1731–1740 (Oct)

Article  Google Scholar 

Shapiro J, van Lanschot JJB, Hulshof MCCM, van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL, van Laarhoven HWM, Nieuwenhuijzen GAP, Hospers GAP, Bonenkamp JJ, Cuesta M, Blaisse R, Busch O, ten Kate FJW, Creemers GM, Punt C, Plukker JTM, Verheul HMW, Spillenaar BEJ, van Dekken H, van der Sangen MJC, Rozema T, Biermann K, Beukema JC, Piet AHM, van Rij CM, Reinders JG, Tilanus HW, Steyerberg EW, van der Gaast A (2015) Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial. Lancet Oncol 16(9):1090–1098

Article  PubMed  Google Scholar 

O’Sullivan B, Davis AM, Turcotte R, Bell R, Catton C, Chabot P, Wunder J, Kandel R, Goddard K, Sadura A, Pater J, Zee B (2002) Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial. Lancet 359(9325):2235–2241

Article  PubMed  Google Scholar 

Ferrandina G et al (2007) Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome, and prognostic measures. Gynecol Oncol 107(1):S127–32

Article  PubMed  CAS  Google Scholar 

Mancuso S et al (2000) Phase I–II trial of preoperative chemoradiation in locally advanced cervical carcinoma. Gynecol Oncol 78(3):324–328

Article  PubMed  CAS  Google Scholar 

Mariagrazia D et al (2005) Preoperative chemoradiotherapy in locally advanced cervical cancer: long-term outcome and complications. Gynecol Oncol 99(3):S166–70

Article  PubMed  Google Scholar 

Klyuchko KO, Gargin VV (2020) Influence of neoadjuvant chemoradiotherapy for locally advanced cervical cancer. Pol Merkur Lekarski 22;48(288):406–409 (Dec)

Google Scholar 

Classe JM et al (2006) Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer). Gynecol Oncol 102(3):523–529

Article  PubMed  CAS  Google Scholar 

Houvenaeghel G, Lelievre L, Gonzague-Casabianca L, Buttarelli M, Moutardier V, Goncalves A et al (2006) Long-term survival after concomitant chemoradiotherapy prior to surgery in advanced cervical carcinoma. Gynecol Oncol 100(2):338–343

Article  PubMed  Google Scholar 

Fokas E, Schlenska-Lange A, Polat B et al (2022) Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial. JAMA Oncol 8(1):e215445

Article  PubMed  Google Scholar 

Conroy T, Bosset JF, Etienne PL, Rio E, Francois E, Mesgouez-Nebout N et al (2021) Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 22:702–715

Article  PubMed  CAS  Google Scholar 

Mishra GD, Chung HF, Pandeya N, Dobson AJ, Jones L, Avis NE, Crawford SL, Gold EB, Brown D, Sievert LL, Brunner E, Cade JE, Burley VJ, Greenwood DC, Giles GG, Bruinsma F, Goodman A, Hayashi K, Lee JS, Mizunuma H, Kuh D, Cooper R, Hardy R, Obermeyer CM, Lee KA, Simonsen MK, Yoshizawa T, Woods NF, Mitchell ES, Hamer M, Demakakos P, Sandin S, Adami HO, Weiderpass E, Anderson D (2016) The InterLACE study: Design, data harmonization and characteristics across 20 studies on women’s health. Maturitas. https://doi.org/10.1016/j.maturitas.2016.07.021

Article  PubMed  PubMed Central  Google Scholar 

Li K et al Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial. Lancet Oncol 25(1):76–85

Mayadev J, Nunes AT, Li M, Marcovitz M, Lanasa MC, Monk BJCALLA (2020) Efficacy and safety of concurrent and adjuvant durvalumab with chemoradiotherapy versus chemoradiotherapy alone in women with locally advanced cervical cancer: a phase III, randomized, double-blind, multicenter study. Int J Gynecol Cancer 30(7):1065–1070. https://doi.org/10.1136/ijgc-2019-001135 (Epub 2020 May 23. PMID: 32447296; PMCID: PMC7398223)

Article  PubMed  PubMed Central  Google Scholar 

Höckel M, Horn LC, Manthey N, Braumann UD, Wolf U, Teichmann G, Frauenschläger K, Dornhöfer N, Einenkel J (2009) Resection of the embryologically defined uterovaginal (Müllerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis. Lancet Oncol 10(7):70100–70107. https://doi.org/10.1016/S1470-2045

Article  Google Scholar 

Eyck BM, van Lanschot JJB, Hulshof MCCM, van der Wilk BJ, Shapiro J, van Hagen P, van Berge Henegouwen MI, Wijnhoven BPL, van Laarhoven HWM, Nieuwenhuijzen GAP, Hospers GAP, Bonenkamp JJ, Cuesta MA, Blaisse RJB, Busch OR, Creemers GM, Punt CJA, Plukker JTM, Verheul HMW, Spillenaar BEJ, van der Sangen MJC, Rozema T, Ten KFJW, Beukema JC, Piet AHM, van Rij CM, Reinders JG, Tilanus HW, Steyerberg EW, van der Gaast A, CROSS Study Group. Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer (2021) The Randomized Controlled CROSS Trial. J Clin Oncol 20;39(18):1995–2004 (Jun)

Article  Google Scholar 

Sardi J, Sananes C, Giaroli A et al (1990) Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol 38(3):486–493

Article  PubMed  CAS  Google Scholar 

Qin AQ et al (2016) Significant Efficacy of Additional Concurrent Chemotherapy with Radiotherapy for Postoperative Cervical Cancer with Risk Factors: a Systematic Review and Meta-analysis. Asian Pac J Cancer Prev 17(8):3945–3951

PubMed  Google Scholar 

Kurrumeli D, Oechsner M, Weidenbächer B, Brambs C, Löffler M, Combs SE, Borm K, Duma MN (2021) An easy way to determine bone mineral density and predict pelvic insufficiency fractures in patients treated with radiotherapy for cervical cancer. Strahlenther Onkol 197(6):487–493 (Jun)

Article  PubMed  Google Scholar 

Rahimy E, von Eyben R, Lewis J, Hristov D, Kidd E (2022) Evaluating dosimetric parameters predictive of hematologic toxicity in cervical cancer patients undergoing definitive pelvic chemoradiotherapy. Strahlenther Onkol 198(9):773–782 (Sep)

Article  PubMed  Google Scholar